Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis

Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis

Summary: Background: We aimed to evaluate overall survival in US patients with amyotrophic lateral sclerosis (ALS) treated with intravenous (IV) edaravone compared with those not treated with IV edaravone in a real-world setting. Methods: This exploratory retrospective comparative effectiveness obs...

Full description

Bibliographic Details
Main Authors: Benjamin Rix Brooks, James D. Berry, Malgorzata Ciepielewska, Ying Liu, Gustavo Suarez Zambrano, Jeffrey Zhang, Melissa Hagan
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:EClinicalMedicine
Subjects:
Amyotrophic lateral sclerosis
Edaravone
Real-world evidence
Survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537022003200

Internet

http://www.sciencedirect.com/science/article/pii/S2589537022003200

Similar Items